Main Menu
MDS-Bio1
Trial Overview
Molecular and functional characterisation of bone marrow function in normal subjects, myelodysplastic syndromes (MDS) and secondary disorders of haematopoiesis
Inclusion criteria
i) Patients with an abnormal blood count requiring investigation by blood and bone marrow sample.
ii) Patients known to have a blood disorder who are having a bone marrow sample taken as part of the assessment of that disorder.
Control subjects
Patients having elective orthopaedic surgery who have a normal blood count.
Exclusion criteria
i) Age < 18.
Controls
i) Age <18.
ii) On treatment likely to impair bone marrow function
iii) History of having had treatment likely to have impaired bone marrow function
Principal Investigator
Prof. David Bowen
Tel: 0113 2068481
E-mail: david.bowen@leedsth.nhs.uk
Research Nurse
Catherine Levy
Tel: 0113 2068577
E-mail: catherine.levy@leedsth.nhs.uk

Print this page
Other trials currently active for Myelodysplastic Syndromes

REDDS
Red blood cell transfusion thresholds and QoL in myelodysplastic syndromes: a pilot, feasibility study